Mr. Speaker, I yield myself such time as I may consume. Section 203 of the Federal Power Act establishes requirements for the sale, disposition, merger, purchase, and acquisition of certain utility assets and facilities. In the Energy Policy Act of 2005, Congress amended section 203 by dividing the section into separate statutory subsections, adding a new subsection granting FERC jurisdiction to review sales of certain generating facilities and increasing the minimum monetary threshold from $50,000 to $10 million for three of the four statutory subsections. This monetary threshold serves as a floor to ensure that public utilities would only be required to file and FERC to review proposed transactions of a minimal material significance. As amended by Congress in 2005, the subsection in section 203 of the Federal Power Act that pertains to mergers and consolidations of FERC jurisdictional facilities did not include an express minimum monetary threshold of $10 million or any other amount. FERC has since interpreted this statutory change as eliminating the de minimis exceptions for mergers and consolidations. As a result, mergers and consolidations of any amount, no matter how small, require FERC approval. This legislation, H.R. 4427, which was introduced by Mr.…
Share & report
More from Ed Whitfield
Mr. Speaker, I ask unanimous consent that all Members may have 5 legislative days to revise and extend their remarks and to include extraneous material on the bill, H.R. 3797. The SPEAKER pro tempore. Is there objection to the request of…
Mr. Chairman, I yield myself such time as I may consume. It is not often that Congress has the opportunity to help an industry that creates both jobs and energy while also improving the environment, and it is especially rare when we can do…
Mr. Speaker, I would like to inquire how much time is remaining on both sides. The SPEAKER pro tempore. The gentleman from Kentucky has 4\3/4\ minutes remaining. The gentleman from Illinois has 4 minutes remaining.
These new technologies and life-saving medical treatments are critical to develop and deploy at a timely pace.





